Protein C News and Research

RSS

Study finds SARS-CoV-2 infection is proportional to cell surface ACE2 levels

Researchers from Oregon State University have developed a system to assess the ability of SARS-CoV-2 to bind to ACE2 orthologs.

26 Oct 2021

Mapping C. difficile: Advanced ribotyping technology helps researchers keep track of deadly disease

Interview with Seth Walk, Principal Investigator and Associate Professor, Department of Microbiology and Cell Biology, Montana State University

From Promega Corporation 26 Oct 2021

MIP Diagnostics to support the development of challenging affinity reagents with new Molecular Imprinting Epitope Discovery

MIP Diagnostics has today announced the launch of its novel Molecular Imprinting Epitope Discovery Service.

26 Oct 2021

Study identifies how cancer cells transform macrophages into supporters of their growth

A Ludwig Cancer Research study has identified a means by which cancer cells engineer the conversion of immune cells known as macrophages from destroyers of tumors to supporters of their growth and survival.

26 Oct 2021

Sexually dimorphic placental antibody transfer during SARS-CoV-2 infection

In a paper recently published in the journal Science Translational Medicine by Bordt et al. (October 19th, 2021), maternal SARS-CoV-2 infections are studied with particular regard to maternal-fetal antibody transfer and virus-induced placental interferon responses, finding a sexually dimorphic response that results in lesser antibody transfer to the male fetus.

26 Oct 2021

Immune response to mRNA COVID vaccines delayed in pregnant women

Researchers in the United States have conducted comprehensive profiling of humoral immune responses in pregnant, lactating, and non-pregnant women following coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccination to probe differences in vaccine-induced immunity.

25 Oct 2021

UCL researchers record sharpest images ever of living bacteria

The sharpest images ever of living bacteria have been recorded by UCL researchers, revealing the complex architecture of the protective layer that surrounds many bacteria and makes them harder to be killed by antibiotics.

25 Oct 2021

N501Y mutation in SARS-CoV-2 Delta variant is key to breakthrough infections

A study in the Philadelphia area found that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants evolve to become more contagious and resistant to COVID-19 vaccines. In addition, depending on the sublineage, SARS-CoV-2 variants such as the Delta variant led to a three-fold increased risk for vaccine breakthrough cases.

25 Oct 2021

Researchers develop ferritin-based nanomedicine for targeted delivery of leukemia therapy

Researchers from the Institute of Process Engineering\ of the Chinese Academy of Sciences, Peking University and Zhujiang Hospital of Southern Medical University have developed a ferritin (Fn)-based nanomedicine for targeted delivery of arsenic (As) and efficient therapy against diverse leukemia types.

25 Oct 2021

Regulating blood insulin levels in obese, diabetic patients may help reduce COVID-19 risk

Keeping blood insulin levels within strict, healthy parameters is a daily goal for people with diabetes. But now, researchers from Japan have found that regulating blood insulin levels may even help lower the risk of getting COVID-19.

25 Oct 2021

Can targeting autophagy become a new approach to COVID-19 treatment?

In a recent review, the author discusses autophagy as a contributing mechanism of selected drugs that are currently being evaluated to treat COVID‐19.

25 Oct 2021

A new vaccine approach that could prevent future pandemics

News-Medical speaks to Professor Tomohiro Kurosaki about how he has developed a new vaccine approach that could prevent future pandemics.

25 Oct 2021

Are non-human primates at risk of SARS-CoV-2 exposure through wastewater contact?

Researchers have been investigating the potential for SARS-CoV-2 to spread to NHP through wastewater.

25 Oct 2021

Molecular features of SARS-CoV-2 variant receptor binding

Researchers have been investigating the changes in receptor binding in these variants that increase the danger they pose.

25 Oct 2021

Study finds FDA-approved drug has potent antiviral activity against SARS-CoV-2 and variants of concern

A new study aimed to examine the antiviral potential of atovaquone against the original SARS-CoV-2 strain and other variants of concern.

25 Oct 2021

Role of SARS-CoV-2 infection biomarkers in HIV replication

A new study investigates the role of the S100A8/A9 complex in the replication of HIV.

25 Oct 2021

Blood pressure drug increases SARS-CoV-2 receptors in transmission and pathogenesis associated tissues

A new study aimed to determine whether ACE2 targeting drugs change the tissue levels of ACE2 in healthy mice.

25 Oct 2021

Study suggests seropositive individuals produce anti-SARS-CoV-2 antibodies with improved potency and breadth

Researchers isolated single cells among individuals with and without prior infection with the SARS-CoV-2 vaccinated with BNT162b2 mRNA vaccine and compared the nature of the neutralizing antibody response against the original Wuhan virus and the subsequent variants.

25 Oct 2021

SARS-CoV-2 Delta variant transmitted by fully vaccinated individuals in Provincetown, Massachusetts

A new study, posted to the medRxiv* preprint server, describes the genomic epidemiology of this outbreak. It provides a deeper understanding of viral transmission from and between fully vaccinated individuals.

25 Oct 2021

New Spex Genomax 2050 accelerates the extraction of molecules

Obtain fast and efficient extraction of nucleic acids, proteins, and other molecules with the new Spex® Genomax® 2050; a high-throughput plant and animal tissue homogenizer and cell lyser designed for rapid cell disruption, cell lysis and tissue homogenization through bead beating.

From SPEX SamplePrep 25 Oct 2021

Protein C News and Research

Study finds SARS-CoV-2 infection is proportional to cell surface ACE2 levels

Mapping C. difficile: Advanced ribotyping technology helps researchers keep track of deadly disease

MIP Diagnostics to support the development of challenging affinity reagents with new Molecular Imprinting Epitope Discovery

Study identifies how cancer cells transform macrophages into supporters of their growth

Sexually dimorphic placental antibody transfer during SARS-CoV-2 infection

Immune response to mRNA COVID vaccines delayed in pregnant women

UCL researchers record sharpest images ever of living bacteria

N501Y mutation in SARS-CoV-2 Delta variant is key to breakthrough infections

Researchers develop ferritin-based nanomedicine for targeted delivery of leukemia therapy

Regulating blood insulin levels in obese, diabetic patients may help reduce COVID-19 risk

Can targeting autophagy become a new approach to COVID-19 treatment?

A new vaccine approach that could prevent future pandemics

Are non-human primates at risk of SARS-CoV-2 exposure through wastewater contact?

Molecular features of SARS-CoV-2 variant receptor binding

Study finds FDA-approved drug has potent antiviral activity against SARS-CoV-2 and variants of concern

Role of SARS-CoV-2 infection biomarkers in HIV replication

Blood pressure drug increases SARS-CoV-2 receptors in transmission and pathogenesis associated tissues

Study suggests seropositive individuals produce anti-SARS-CoV-2 antibodies with improved potency and breadth

SARS-CoV-2 Delta variant transmitted by fully vaccinated individuals in Provincetown, Massachusetts

New Spex Genomax 2050 accelerates the extraction of molecules

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News